RespirasenseStatus:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
Dapsone for treating COVID-19 in people 40 years and over with high-risk comorbidity and people 70 years and over [TSID11892]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: TBC
Cytokine adsorption technologies for treating respiratory failure in people with COVID-19Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
CFHealthHub for managing cystic fibrosis during the COVID-19 pandemicStatus:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
FebriDx for C-reactive protein and myxovirus resistance protein A testingStatus:Topic prioritisationProgramme:Diagnostics guidanceExpected publication date: TBC
Syne Covid for predicting COVID-19 outcomes MT655Status:Topic prioritisationProgramme:Diagnostics guidanceExpected publication date: TBC
RespiraSense (MT736)Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC